Brief: Klaria Signs Agreement For EU Grant Worth CA. 21 Msek To Take Migraine Product To Market
Klaria Pharma Holding AB (publ) KLAR.ST :
* KLARIA SIGNS AGREEMENT FOR EU GRANT WORTH CA. 21 MSEK TO
TAKE
MIGRAINE PRODUCT TO MARKET
* GRANT WILL, AS ANNOUNCED EARLIER, BE USED TO FINALIZE
DEVELOPMENT AND COMMERZIALISATION OF KL-00119,
Source text for Eikon: ID:nWkr9mFF80
Further company coverage: KLAR.ST
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement